ANNX
Annexon Inc

1,179
Mkt Cap
$739.56M
Volume
10.01M
52W High
$7.18
52W Low
$1.29
PE Ratio
-3.63
ANNX Fundamentals
Price
$5.11
Prev Close
$5.49
Open
$5.45
50D MA
$5.73
Beta
1.11
Avg. Volume
2.32M
EPS (Annual)
-$1.01
P/B
3.64
Rev/Employee
$0.00
$421.84
Loading...
Loading...
News
all
press releases
Annexon's (ANNX) "Buy" Rating Reaffirmed at Chardan Capital
Chardan Capital restated a "buy" rating and set a $16.00 target price on shares of Annexon in a research report on Friday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4
Annexon (NASDAQ:ANNX) used its Investor Day presentation to outline the scientific rationale and clinical progress for vonoprument (ANX007), an intravitreal therapy being developed for geographic atrophy (GA) secondary to dry age-related macular degeneration. Company leaders and invited retinal expe...
MarketBeat·3d ago
News Placeholder
William Carson Buys 8,000 Shares of Annexon (NASDAQ:ANNX) Stock
Annexon, Inc. (NASDAQ:ANNX - Get Free Report) Director William Carson acquired 8,000 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was acquired at an average cost...
MarketBeat·8d ago
News Placeholder
William Carson Acquires 8,000 Shares of Annexon (NASDAQ:ANNX) Stock
Annexon, Inc. (NASDAQ:ANNX - Get Free Report) Director William Carson bought 8,000 shares of the business's stock in a transaction on Tuesday, March 10th. The shares were acquired at an average price...
MarketBeat·9d ago
News Placeholder
Annexon (NASDAQ:ANNX) Stock Price Down 8.1% - Should You Sell?
Annexon (NASDAQ:ANNX) Stock Price Down 8.1% - Should You Sell...
MarketBeat·9d ago
News Placeholder
Annexon (NASDAQ:ANNX) Shares Up 6.8% - Time to Buy?
Annexon (NASDAQ:ANNX) Stock Price Up 6.8% - Here's What Happened...
MarketBeat·12d ago
News Placeholder
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference
Annexon (NASDAQ:ANNX) highlighted progress across three programs targeting the classical complement pathway during a fireside chat at TD Cowen's 46th Annual Healthcare Conference, with President and...
MarketBeat·18d ago
News Placeholder
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are currently covering the firm, Marketbeat.com reports...
MarketBeat·20d ago
News Placeholder
Annexon (ANNX) to Release Earnings on Monday
Annexon (NASDAQ:ANNX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...
MarketBeat·27d ago
News Placeholder
Annexon (NASDAQ:ANNX) EVP Sells $40,149.27 in Stock
Annexon, Inc. (NASDAQ:ANNX - Get Free Report) EVP Ted Yednock sold 7,857 shares of the firm's stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $5.11...
MarketBeat·29d ago
<
1
2
...
>

Latest ANNX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.